274 filings
Page 2 of 14
8-K
amc95 67ch
7 Aug 23
Results of Operations and Financial Condition
4:54pm
S-8
kexqwfis9 9tugok4mod
23 Jun 23
Registration of securities for employees
4:51pm
8-K
ewdr 94jfbvw68ny
15 May 23
Executing a Plan For Growth and Profitability With a Balance Sheet Bolstered By Approximately $12.7 Million Raised in 2023
5:40pm
8-K
z2udswg4wm vfrq3wgc5
26 Apr 23
ReShape Lifesciences Announces Pricing of $2.5 Million Registered Direct Offering and Concurrent Private Placement Priced At-The-Market
4:06pm
424B5
5f76a
24 Apr 23
Prospectus supplement for primary offering
9:06am
8-K
4ekoky
13 Apr 23
Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review
5:24pm
NT 10-K
ykv94a38hmq1 knh6
3 Apr 23
Notice of late annual filing
5:11pm
8-K
gi0cziavz4 zp
21 Mar 23
Entry into a Material Definitive Agreement
4:18pm
8-K
pzvjcx27d55b x1
10 Feb 23
ReShape Lifesciences Announces Pricing of Upsized
4:05pm
424B4
hy97m1bnvli5b dnv
8 Feb 23
Prospectus supplement with pricing info
9:01am
EFFECT
cj2 0axrlu1j
6 Feb 23
Notice of effectiveness
12:15am
S-1MEF
q2gb5y513ec9h9frg
3 Feb 23
Registration of additional securities for an S-1
8:01pm
CORRESP
hehgv36qjnys
3 Feb 23
Correspondence with SEC
12:00am
CORRESP
8rwdr jcj469yt4
3 Feb 23
Correspondence with SEC
12:00am
RW WD
dat1q j8fu
2 Feb 23
Withdrawal of registration withdrawal request
8:01pm